Milnubes / Curiosity, with sourcesBotany · Culture · Science
milnubes.
Milnubes/Encyclopedia/HHCH
Cannabinoid atlas / Reference entry
HHCH
Semisynthetic & derivatives

Hexahydrocannabihexol

HHCH belongs to the HHC analogue family, but substance-specific data remain scarce. Forensic identification, metabolism research and published poisoning cases exist. These help frame relevant questions, not assign benefits or a precise human potency.

Documentary review: Milnubes editorial desk · assisted by AI
A researcher wearing protective glasses uses a laboratory microscope.
Stock photograph providing context for this entry. It does not document a trial, participant, identified product or HHCH result.
Evidence map

Mixed evidence by question. This label summarises the type of data; it is neither a recommendation to use nor a safety rating.

How we read studies and personal accounts ↗

Identity

The name denotes the analogue with a six-carbon side chain. HHCH, HHC and HHCP are not three equivalent spellings: the chemical distinction must be retained when reading an analysis or a news story.

Source · HHCH: New Drug Monograph

Terms associated with this entry: hexahydrocannabihexol, HHC-C6.

A place in the laboratory, still few answers

A 2025 study included HHCH in a metabolism comparison using human liver microsomes. Studying how a molecule changes helps laboratories look for it. It does not demonstrate symptom improvement or, by itself, describe what a person will experience.

Source · In Vitro Metabolic Profiling of 18 Semi-Synthetic Cannabinoids—HHC and Its Analogs—with Identification in an Authentic HHCP Urine Sample

Reading a case without erasing its circumstances

In 2026, two cases of nausea and tremor were published in connection with gummies described as HHCH products. Both involved alcohol. That matters: it identifies a clinical signal but limits what can be attributed exclusively to HHCH.

Source · Cases of acute poisoning by cannabis-like substances: Case reports

What has been studied

No established clinical benefit

No controlled human therapeutic trials were located. A metabolism study does not fill that gap.

Source · In Vitro Metabolic Profiling of 18 Semi-Synthetic Cannabinoids—HHC and Its Analogs—with Identification in an Authentic HHCP Urine Sample

Risks and gaps

Published cases describe acute illness; they do not establish an incidence or a complete safety profile.

Source · Cases of acute poisoning by cannabis-like substances: Case reports

Documented forms

Gummies described in clinical casesThe form comes from the case report, without extending its composition to other products.
Source · Cases of acute poisoning by cannabis-like substances: Case reports

A molecule and a product are different things. Read about flowers, resins, oils, creams, capsules and vaping.

Experiences

We have not included a verifiable individual account in this review. We do not fill that gap with commercial stories or invented experiences.

Conclusion

HHCH is an identity requiring its own data. Resembling another molecule does not allow it to inherit that molecule’s evidence or have its risks dismissed.

Legal context

Read the Spain note and official sources. Absence from a cited list does not establish that a product is lawful.

Sources

  1. HHCH: New Drug Monograph · Laboratory study
  2. In Vitro Metabolic Profiling of 18 Semi-Synthetic Cannabinoids—HHC and Its Analogs—with Identification in an Authentic HHCP Urine Sample · Laboratory study
  3. Cases of acute poisoning by cannabis-like substances: Case reports · Original research

Source review: 2026-11-02. No external clinical review. Corrections: info@milnubes.com.